Selpercatinib

Definition: Selpercatinib, sold under the brand name Retevmo among others, is a targeted medication for the treatment of cancers in people whose tumors have an alteration (mutation or fusion) in a specific gene (RET which is short for "rearranged during transfection"). Before beginning treatment, the identification of a RET gene alteration must be determined using laboratory testing. Selpercatinib is taken by mouth. source: Wikipedia

ID

876841001

ID date

7 Jan 2022

Previous ID

39390111000001107

Name

Selpercatinib